Gaël-Sean Marqueyssat

Exposure to Guideline-Recommended Quadruple Therapy after First Hospitalisation for HFrEF in France

Abstract Introduction In 2021, the European Society of Cardiology updated its guidelines for managing heart failure with reduced left ventricular ejection fraction (HFrEF), recommending a four-drug regimen combining an SGLT2 inhibitor, a beta-blocker, a mineralocorticoid receptor...